In our previous publications (Bishop et al. 2012; Bishop et al. 2013) we investigated the biochemical bases of the ALAS2 exon 11 carboxyl-terminal mutations that cause XLP and XLSA. Here, ALAS2 is linked to X-linked lymphoproliferative disease.